# The Role of Peripheral Afferents in Modulating Post-stroke Central Pain

> **NCT06446960** · PHASE3 · RECRUITING · sponsor: **Institut National de la Santé Et de la Recherche Médicale, France** · enrollment: 36 (estimated)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Lidocaine 20mg/ml
- **DRUG:** Levobupivacaine Hydrochloride 1.25 MG/ML
- **DRUG:** Sodium Chloride 0.9% Inj

## Key facts

- **NCT ID:** NCT06446960
- **Lead sponsor:** Institut National de la Santé Et de la Recherche Médicale, France
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-09
- **Primary completion:** 2026-09-08
- **Final completion:** 2026-09-08
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06446960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06446960, "The Role of Peripheral Afferents in Modulating Post-stroke Central Pain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06446960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*